Parkinson’s Disease Market is anticipated to Grow at a CAGR of 5.8% During the Study Period (2020-2034) by DelveInsight
According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...
Knowridge2d
Research shows major causes of Parkinson’s disease and dementia
Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
News Medical9d
Alzheimer’s and Parkinson’s linked to aging brain’s failing waste disposal
New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...
biopharma-reporter10d
Inhibikase to pause development of Parkinson’s drug
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, ...
Inhibikase Halts Parkinson's Drug Development to Focus on PAH
Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...
Armed robbery in Revesby12d
Research Links Sleep Disorder to Parkinson's Disease
U.S. Department of Defense awards $4 million to researchers at OHSU, University of Washington, VA Portland, VA Puget Sound to ...
Hosted on MSN14d
Parkinson's disease could be treated by FDA-approved cancer drug after major research breakthrough
A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the spread of brain proteins believed to be responsible for Parkinson's ...
C&EN16d
Chronic DSS-Induced Colitis Exacerbates Parkinson’s Disease Phenotype and Its Pathological Features Following Intragastric Rotenone Exposure
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, Gujarat, India Department of Pharmacology and Toxicology, College of ...
Science Daily16d
Biotin may shield brain from manganese-induced damage, study finds
The B vitamin mitigates manganese neurotoxicity, which produces symptoms that resemble Parkinson's disease. The vitamin improves dopamine production in the brain and offers potential therapeutic ...
Knowridge16d
Research shows big cause of Parkinson’s disease and memory disorders
Parkinson’s disease is a brain condition that makes ... One protein involved is alpha-synuclein. In healthy brains, alpha-synuclein is cleared out through autophagy. But in people with Parkinson ...
verywellhealth16d
Parkinson’s Disease
Although there is no cure for Parkinson's disease, medications and surgery can help relieve some of the symptoms. Alpha-synuclein is a protein in the human brain that’s involved in the release of ...